Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Hypophosphatemia is Associated with the Serial Administration of Triple-Dose Gadolinium to Patients for Brain MRI.
Utilized Resources of Hope, Orientation, and Inspiration in Life of Persons with Multiple Sclerosis and Their Association with Life Satisfaction, Adaptive Coping Strategies, and Spirituality.
Pediatric multiple sclerosis.
[Alemtuzumab is a new drug based on monoclonal antibodies for treatment multiple sclerosis: treatment possibilities and risks(review)].
Altered microglia morphology and higher resilience to stress-induced depression-like behavior in CX3CR1-deficient mice.
No evidence for an association of osteopontin plasma levels with disease activity in multiple sclerosis.
Systematic review and meta-analysis of pharmacological therapies for pain associated with postherpetic neuralgia and less common neuropathic conditions.
The current role of mitoxantrone in the treatment of multiple sclerosis.
Is there any relation between chronic cerebrospinal venous insufficiency and multiple sclerosis? - a critical review.
Subretinal angiostrongyliasis-induced optic neuritis.
Gray Matter Pathology in MS: Neuroimaging and Clinical Correlations.
Serum analysis by 1H Nuclear Magnetic Resonance spectroscopy: a new tool for distinguishing neuromyelitis optica from multiple sclerosis.
Efficacy and safety of natalizumab treatment for relapsing-remitting multiple sclerosis: interim results of the tysabri(r) observational programme in the uk.
A case of fulminant neuromyelitis optica presenting with destructive lesions in whole-brain.
Pseudobulbar affect: prevalence and management.
Transorbital sonography in CIDP patients: No evidence for optic nerve hypertrophy.
Grb2 Is Important for T Cell Development, Th Cell Differentiation, and Induction of Experimental Autoimmune Encephalomyelitis.
The Relationships Between Apathy and Executive Dysfunction in Multiple Sclerosis.
A 12-month prospective, observational study evaluating the impact of disease-modifying treatment on emotional burden in recently-diagnosed multiple sclerosis patients: The POSIDONIA study.
Conjugal multiple sclerosis in Isfahan, Iran: a population-based study.
Successful treatment of neuromyelitis optica spectrum disorder by early initiation of plasma exchange.
Pharmacological approaches to intervention in hypomyelinating and demyelinating white matter pathology.
Multiple Sclerosis Risk Allele in CLEC16A Acts as an Expression Quantitative Trait Locus for CLEC16A and SOCS1 in CD4+ T Cells.
Multiple sclerosis relapse phenotype is an important, neglected determinant of disease-outcome: Commentary.
Iron Oxide as an MRI Contrast Agent for Cell Tracking.
Pages
« first
‹ previous
…
586
587
588
589
590
591
592
593
594
…
next ›
last »